Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1

Neuroscience

Volumn 147, Issue 1, 2007, Pages 18-27

  O'Tuathaigh, C M P ^a   Babovic, D ^a   O'Sullivan, G J ^a   Clifford, J J ^a   Tighe, O ^a   Croke, D T ^a   Harvey, R ^b   Waddington, J L ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

behavioral phenotype; mutant model; psychosis; social interaction; spatial working memory; targeted gene deletion

Indexed keywords

NEU DIFFERENTIATION FACTOR;

AGGRESSION; ANIMAL EXPERIMENT; ANOSMIA; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; KNOCKOUT MOUSE; LEARNING; MALE; MAZE TEST; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL DOMINANCE; SPATIAL MEMORY; WORKING MEMORY;

AGGRESSION; ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; GENE DELETION; HETEROZYGOTE; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUREGULIN-1; REACTION TIME; RISK FACTORS; SCHIZOPHRENIA; SMELL; SOCIAL BEHAVIOR;

EID: 34249888202     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.03.051     Document Type: Article

References (65)

1. Addington J., Saeedi H., and Addington D. The course of cognitive functioning in first episode psychosis: Changes over time and impact on outcome. Schizophr Res 78 (2005) 35-43
2. Alberts J.R., and Galef B.G. Acute anosmia in the rat: a behavioral test of a peripherally-induced olfactory deficit. Physiol Behav 6 (1971) 619-621
3. Andreasen N.C. Schizophrenia: the fundamental questions. Brain Res Brain Res Rev 31 (2000) 106-112
4. Anton E.S., Ghashghaei H.T., Weber J.L., McCann C., Fischer T.M., Cheung I.D., Gassmann M., Messing A., Klein R., Schwab M.H., Lloyd K.C., and Lai C. Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat Neurosci 7 (2004) 1319-1328
5. Arguello P.A., and Gogos J.A. Modeling madness in mice: One piece at a time. Neuron 52 (2006) 179-196
6. Bach M.E., Hawkins R.D., Osman M., Kandel E.R., and Mayford M. Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency. Cell 81 (1995) 905-915
7. Bassareo V., De Luca M.A., and Di Chiara G. Differential expression of motivational stimulus properties by dopamine in nucleus accumbens shell versus core and prefrontal cortex. J Neurosci 22 (2002) 4709-4719
8. Bovetti S., De Marchis S., Gambarotta G., Fasolo A., Perroteau I., Puche A.C., and Bovolin P. Differential expression of neuregulins and their receptors in the olfactory bulb layers of the developing mouse. Brain Res 1077 (2006) 37-47
9. Bowie C.R., and Harvey P.D. Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr Clin North Am 28 (2005) 613-633
10. Brodkin E.S., Hagemann A., Nemetski S.M., and Silver L.M. Social approach-avoidance behavior of inbred mouse strains towards DBA/2 mice. Brain Res 1002 (2004) 151-157
11. Chang Q., and Fischbach G.D. An acute effect of neuregulin 1 beta to suppress alpha7-containing nicotinic acetylcholine receptors in hippocampal interneurons. J Neurosci 26 (2006) 11295-11303
12. Chen J., Lipska B.K., and Weinberger D.R. Genetic mouse models of schizophrenia: from hypothesis-based to susceptibility gene-based models. Biol Psychiatry 59 (2006) 1180-1188
13. Corfas G., Rosen K.M., Aratake H., Krauss R., and Fischbach G.D. Differential expression of ARIA isoforms in the rat brain. Neuron 14 (1995) 103-115
14. Corvin A., Morris D.W., McGhee K., Schwaiger S., Scully P., Quinn J., Meagher D., Clair D.S., Waddington J.L., and Gill M. Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster Hs. 97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol Psychiatry 9 (2004) 208-213
15. Coyle J.T., and Tsai G. NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. Int Rev Neurobiol 59 (2004) 491-515
16. De Leonibus E., Verheij M.M., Mele A., and Cools A. Distinct kinds of novelty processing differentially increase extracellular dopamine in different brain regions. Eur J Neurosci 23 (2006) 1332-1340
17. Duncan G.E., Moy S.S., Perez A., Eddy D.M., Zinzow W.M., Lieberman J.A., Snouwaert J.N., and Koller B.H. Deficits in sensorimotor gating and tests of social behaviour in a genetic model of reduced NMDA receptor function. Behav Brain Res 153 (2004) 507-519
18. Esper R.M., Pankonin M.S., and Loeb J.A. Neuregulins: versatile growth and differentiation factors in nervous system development and human disease. Brain Res Brain Res Rev 51 (2006) 161-175
19. Falls D.L. Neuregulins: functions, forms and signalling strategies. Exp Cell Res 284 (2003) 14-30
20. Freedman R. Schizophrenia. N Engl J Med 349 (2003) 1738-1749
21. Gerlai R., Pisacane P., and Erickson S. Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioural tasks. Behav Brain Res 109 (2000) 219-227
22. Hahn C.-G., Wang H.-Y., Cho D.-S., Talbot K., Gur R.E., Berretini W.H., Bakshi K., Kamins J., Borgmann-Winter K.E., Siegel S.J., Gallop R.J., and Arnold S.E. Altered neuregulin-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 12 (2006) 824-828
23. Hall J., Whalley H.C., Job D.E., Baig B.J., McIntosh A.M., Evans K.L., Thomson P.A., Porteous D.J., Cunningham-Owens D.G., Johnstone E.C., and Lawrie S.M. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci 9 (2006) 1477-1478
24. Harrison P.J., and Law A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 60 (2006) 132-140
25. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10 (2005) 40-68
26. Hashimoto R., Straub R.E., Weickert C.S., Hyde T.M., Kleinman J.E., and Weinberger D.R. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 9 (2004) 299-307
27. Holmes A., Wrenn C.C., Harris A.P., Thayer K.E., and Crawley J.N. Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav 1 (2002) 55-69
28. Inman-Wood S.L., Williams M.T., Morford L.L., and Vorhees C.V. Effects of prenatal cocaine on Morris and Barnes maze tests of spatial learning and memory in the offspring of C57BL/6J mice. Neurotoxicol Teratol 22 (2000) 547-557
29. Kapur S., Mizrahi R., and Li M. From dopamine to salience to psychosis: linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 79 (2005) 59-68
30. Karayiorgou M., and Gogos J.A. Schizophrenia genetics: uncovering positional candidate genes. Eur J Hum Genet 14 (2006) 512-519
31. Kerber G., Streif R., Schwaiger F.W., Kreutzberg G.W., and Hager G. Neuregulin-1 isoforms are differentially expressed in the intact and regenerating adult rat nervous system. J Mol Neurosci 21 (2003) 149-165
32. Koopmans G., Blokland A., van Nieuwenhuijzen P., and Prickaerts J. Assessment of spatial learning abilities of mice in a new circular maze. Physiol Behav 79 (2003) 683-693
33. Law A.J., Shannon Weickert C., Hyde T.M., Kleinman J.E., and Harrison P.J. Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain. Neuroscience 127 (2004) 125-136
34. Law A.J., Lipska B.K., Weickert C.S., Hyde T.M., Straub R.E., Hashimoto R., Harrison P.J., Kleinman J.E., and Weinberger D.R. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc Natl Acad Sci U S A 103 (2006) 6747-6752
35. Leonard S., and Freedman R. Genetics of chromosome 15q13-q14 in schizophrenia. Biol Psychiatry 60 (2006) 115-122
36. Longart M., Liu Y., Karavanova I., and Buonanno A. Neuregulin-2 is developmentally regulated and targeted to dendrites of central neurons. J Comp Neurol 472 (2004) 156-172
37. Malla A., and Payne J. First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr Bull 31 (2005) 650-671
38. Millan M.J. N-methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology 179 (2005) 30-53
39. Mohn A.R., Gainetdinov R.R., Caron M.G., and Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98 (1999) 427-436
40. Moy S.S., Nadler J.J., Perez A., Barbaro R.P., Johns J.M., Magnuson T.R., Piven J., and Crawley J.N. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 3 (2004) 287-302
41. Munafo M.R., Thiselton D.L., Clark T.G., and Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry 11 (2006) 539-546
42. Norton N., Moskvina V., Morris D.W., Bray N.J., Zammit S., Williams N.M., Williams H.J., Preece A.C., Dwyer S., Wilkinson J.C., Spurlock G., Kirov G., Buckland P., Waddington J.L., Gill M., Corvin A.P., Owen M.J., and O'Donovan M.C. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet 141 (2006) 96-101
43. Olincy A., Harris J.G., Johnson L.L., Pender V., Kongs S., Allensworth D., Ellis J., Zerbe G.O., Leonard S., Stevens K.E., Stevens J.O., Martin L., Adler L.E., Soti F., Kem W.R., and Freedman R. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 63 (2006) 630-638
44. O'Sullivan G., Kinsella A., Grandy D.K., Low M.J., Tighe O., Croke D.T., and Waddington J.L. Ethological resolution of behavioural topography and D2-like vs. D1-like agonist responses in congenic D4 dopamine receptor 'knockouts': identification of D4:D1-like interactions. Synapse 59 (2006) 107-118
45. O'Tuathaigh C.M., Salum C., Young A.M., Pickering A.D., Joseph M.H., and Moran P.M. The effect of amphetamine on Kamin blocking and overshadowing. Behav Pharmacol 14 (2003) 315-322
46. O'Tuathaigh C.M., O'Sullivan G.J., Kinsella A., Harvey R.P., Tighe O., Croke D.T., and Waddington J.L. Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice. Neuroreport 17 (2006) 79-83
47. O'Tuathaigh C.M.P., Babovic D., O'Meara G., Clifford J.J., Croke D.T., and Waddington J.L. Susceptibility genes for schizophrenia: phenotypic characterisation of mutant models. Neurosci Biobehav Rev 31 (2007) 60-78
48. Owen M.J., Craddock N., and O'Donovan M.C. Schizophrenia: genes at last?. Trends Genet 21 (2005) 518-525
49. Petrulis A., and Eichenbaum H. The perirhinal-entorhinal cortex, but not the hippocampus, is critical for expression of individual recognition in the context of the Coolidge effect. Neuroscience 122 (2003) 599-607
50. Pompl P.N., Mullan M.J., Bjugstad K., and Arendash G.W. Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APP (SW) transgenic mouse model for Alzheimer's disease. J Neurosci Methods 87 (1999) 87-95
51. Rimer M., Barrett D.W., Maldonado M.A., Vock V.M., and Gonzalez-Lima F. Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. Neuroreport 16 (2005) 271-275
52. Sankoorikal G.M., Kaercher K.A., Boon C.J., Lee J.K., and Brodkin E.S. A mouse model system for genetic analysis of sociability: C57BL/6J versus BALB/cJ inbred mouse strains. Biol Psychiatry 59 (2006) 415-423
53. Seeman P., Schwarz J., Chen J.F., Szechtman H., Perreault M., McKnight G.S., Roder J.C., Quirion R., Boksa P., Srivastava L.K., Yanai K., Weinshenker D., and Sumiyoshi T. Psychosis pathways converge via D2high dopamine receptors. Synapse 60 (2006) 319-346
54. Stefansson H., Sigurdsson E., Steinhorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmondsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., and Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71 (2002) 877-892
55. Steinthorsdottir V., Stefansson H., Ghosh S., Birgisdottir B., Bjornsdottir S., Fasquel A.C., Olafsson O., Stefansson K., and Gulcher J.R. Multiple novel transcription initiation sites for NRG1. Gene 342 (2004) 97-105
56. Stowers L., Holy T.E., Meister M., Dulac C., and Koentges G. Loss of sex discrimination and male-male aggression in mice deficient for TRP2. Science 295 (2002) 1493-1500
57. Thaker G.K., and Carpenter W.T. Advances in schizophrenia. Nat Med 7 (2001) 667-671
58. van Kampen M., Selbach K., Schneider R., Schiegel E., Boess F., and Schreiber R. AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors. Psychopharmacology 172 (2004) 375-383
59. Waddington J.L., Lane A., Larkin C., and O'Callaghan E. The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease. Biol Psychiatry 46 (1999) 31-39
60. Waddington J.L., O'Tuathaigh C., O'Sullivan G., Tomiyama K., Koshikawa N., and Croke D.T. Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface. Psychopharmacology 181 (2005) 611-638
61. Waddington J.L., Kingston T., and O'Tuathaigh C.M.P. Longitudinal studies on course of illness in schizophrenia: a lifetime trajectory perspective. In: Carpenter W., and Thaker G. (Eds). The year in schizophrenia Vol. 1 (2006), Clinical Publishing, Oxford 77-101
62. Wall P.M., and Messier C. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory. Psychopharmacology 160 (2002) 233-244
63. Walss-Bass C., Liu W., Lew D.F., Villegas R., Montero P., Dassori A., Leach R.J., Almasy L., Escamilla M., and Raventos H. A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biol Psychiatry (2006) in press.
64. Yang X., Schadt E.E., Wang S., Wang H., Arnold A.P., Ingram-Drake L., Drake T.A., and Lusis A.J. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res 16 (2006) 995-1004
65. Yurek D.M., Zhang L., Fletcher-Turner A., and Seroogy K.B. Supranigral injection of neuregulin1-beta induces striatal dopamine overflow. Brain Res 1028 (2004) 116-119